-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
NeuBase Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- NeuBase Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$1.82M, a 76.1% increase year-over-year.
- NeuBase Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$13.7M, a 59.4% increase year-over-year.
- NeuBase Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$33.8M, a 32.9% decline from 2021.
- NeuBase Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$25.4M, a 46.2% decline from 2020.
- NeuBase Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$17.4M, a 33.5% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)